X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
acid-esters (1) 1
acrylates - pharmacology (1) 1
acrylic acid (1) 1
activation (1) 1
animals (1) 1
blood-brain barrier - drug effects (1) 1
blood-brain barrier - enzymology (1) 1
blood-brain-barrier (1) 1
brain edema - drug therapy (1) 1
brain edema - enzymology (1) 1
casein (1) 1
casein kinase 2 (1) 1
casein kinase ii - antagonists & inhibitors (1) 1
casein kinase ii - metabolism (1) 1
cerebral hemorrhage - drug therapy (1) 1
cerebral hemorrhage - enzymology (1) 1
collagenases (1) 1
degradation (1) 1
dimethyl fumarate (1) 1
dimethyl fumarate - pharmacology (1) 1
disease models, animal (1) 1
evans blue extravasation (1) 1
fumaric acid (1) 1
health aspects (1) 1
index medicus (1) 1
inflammation (1) 1
injury (1) 1
intercellular adhesion molecule-1 - metabolism (1) 1
intracerebral hemorrhage (1) 1
mafg transcription factor - genetics (1) 1
mafg transcription factor - metabolism (1) 1
male (1) 1
mice (1) 1
microglia - drug effects (1) 1
microglia - enzymology (1) 1
musculo-aponeurotic fibrosarcoma-g (1) 1
neuroblastoma-cells (1) 1
neuroimmunomodulation - drug effects (1) 1
neuroimmunomodulation - physiology (1) 1
neurology (1) 1
neuroprotective agents - pharmacology (1) 1
neurosciences (1) 1
nf-e2-related factor 2 - metabolism (1) 1
oxidative stress (1) 1
permeability (1) 1
phase (1) 1
phosphorylated nuclear factor erythroid-2 related factor 2 (1) 1
phosphorylation - drug effects (1) 1
protein kinase inhibitors - pharmacology (1) 1
rat (1) 1
repressor proteins - genetics (1) 1
repressor proteins - metabolism (1) 1
sarcoma (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neurobiology of Disease, ISSN 0969-9961, 2015, Volume 82, pp. 349 - 358
Abstract Background and purpose Edema formation, inflammation and increased blood–brain barrier permeability contribute to poor outcomes after intracerebral... 
Neurology | Phosphorylated nuclear factor erythroid-2 related factor 2 (Nrf2) | Musculo-aponeurotic fibrosarcoma-G | Evans Blue extravasation | Dimethyl fumarate | Inflammation | Intracerebral hemorrhage | Casein kinase 2 | Evans blue extravasation | OXIDATIVE STRESS | ACTIVATION | RAT | INJURY | BLOOD-BRAIN-BARRIER | NEUROBLASTOMA-CELLS | NEUROSCIENCES | PHASE | DEGRADATION | ACID-ESTERS | Male | Neuroimmunomodulation - physiology | Brain Edema - enzymology | Neuroprotective Agents - pharmacology | Dimethyl Fumarate - pharmacology | Acrylates - pharmacology | Phosphorylation - drug effects | MafG Transcription Factor - metabolism | MafG Transcription Factor - genetics | Repressor Proteins - metabolism | Disease Models, Animal | Cerebral Hemorrhage - drug therapy | Microglia - drug effects | Casein Kinase II - antagonists & inhibitors | Microglia - enzymology | Repressor Proteins - genetics | Blood-Brain Barrier - drug effects | Collagenases | Intercellular Adhesion Molecule-1 - metabolism | Animals | Blood-Brain Barrier - enzymology | NF-E2-Related Factor 2 - metabolism | Cerebral Hemorrhage - enzymology | Brain Edema - drug therapy | Mice | Protein Kinase Inhibitors - pharmacology | Casein Kinase II - metabolism | Neuroimmunomodulation - drug effects | Permeability | Casein | Sarcoma | Fumaric acid | Acrylic acid | Health aspects
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.